BRITTANY WHITENER: Open Payments
NPI 1154747475 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,332 in 87 payments from 16 companies in 2025. Trend: 2023 $1,067 · 2024 $1,329 · 2025 $1,332
Food & beverage: $1,332
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $328 |
| Novo Nordisk Inc | 31 | $308 |
| Lilly USA, LLC | 11 | $150 |
| PFIZER INC. | 4 | $72 |
| Amgen Inc. | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 5 | $55 |
| Astellas Pharma US Inc | 2 | $49 |
| Exact Sciences Corporation | 2 | $45 |
| TOLMAR, INC. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
Products named: AIRSUPRA, Ozempic, KISUNLA, OTEZLA, Wegovy, Rybelsus, MOUNJARO, BREZTRI.
Industry payments across AL — which companies pay providers there.
